Toggle navigation
Home
Search
Services
Blog
Contact
About
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R.
Sts Biopolymers, Inc., Henrietta, NY, United States
Search 16 grants from Michael Violante
Search grants from Sts Biopolymers, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV
Computational Biology
Parent FIT START: Parent Feedback Intervention Targeting Student Transitions &Al
Role of Nogo receptor in addiction
Identification of Francisella tularensis extracellular proteins expressed in vivo
Recently added grants:
Acid-base balance and kidney, bone, and muscle health in Veterans with preserved renal function
Sex hormones and HCV-related liver disease progression
Optimization of Antiplatelet Therapy to Target Platelet-Monocyte Aggregates in Myocardial Infarction
Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder
Biomarker Candidates in Gulf War Veterans: A 10-year Follow-up Investigation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA036615-02A1
Application #
3506361
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1986-09-30
Project End
1988-09-29
Budget Start
1986-09-30
Budget End
1987-09-29
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Sts Biopolymers, Inc.
Department
Type
DUNS #
City
Henrietta
State
NY
Country
United States
Zip Code
14467
Related projects
NIH 1987
R44 CA
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R. / Sts Biopolymers, Inc.
NIH 1986
R44 CA
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R. / Sts Biopolymers, Inc.
Comments
Be the first to comment on Michael Violante's grant